SEC Form 6-K filed by Braskem SA ADR

$BAK
Major Chemicals
Industrials
Get the next $BAK alert in real time by email
6-K 1 bak20250324_6k1.htm 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


For the month of March, 2025

(Commission File No. 1-14862 )

 


 

BRASKEM S.A.

(Exact Name as Specified in its Charter)

 

N/A

(Translation of registrant's name into English)

 


 

Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil

(Address of principal executive offices)

 


 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

 

 
 

 

 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 

 

 

 
 

 

 

 

 
 

 
 

 

 
 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 

 

 

 

 

 

 

 

 

 
 

 

 

 

 
 

 
 

 
 

 
 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 

 

 
 

 

 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 

 
 

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 24, 2025

  BRASKEM S.A.
       
       
  By:      /s/     Felipe Montoro Jens
     
    Name: Felipe Montoro Jens
    Title: Chief Financial Officer

 

DISCLAIMER ON FORWARD-LOOKING STATEMENTS

 

This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.


 

 

 

Get the next $BAK alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BAK

DatePrice TargetRatingAnalyst
3/3/2025Sector Outperform → Sector Perform
Scotiabank
9/18/2024Neutral → Buy
UBS
8/20/2024Neutral → Buy
Citigroup
8/29/2023Neutral → Sell
UBS
7/5/2023$11.50 → $11.00Overweight → Neutral
JP Morgan
6/14/2023Hold → Buy
HSBC Securities
5/18/2023Buy → Neutral
UBS
5/8/2023$16.75Sector Perform → Sector Outperform
Scotiabank
More analyst ratings

$BAK
Press Releases

Fastest customizable press release news feed in the world

See more
  • Braskem reports Recurrent Cash Generation of R$265 million in 4Q24; Recurring EBITDA of US$1.1 billion in 2024 (46% higher than 2023)

    SÃO PAULO, Feb. 27, 2025 /PRNewswire/ -- BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6, NYSE:BAK, LATIBEX: XBRK) the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 4Q24 Earnings Release. 4Q24 HIGHLIGHTS  CONSOLIDATED Recurring EBITDA of US$102 million.Cash position of US$2.4 billion, ensuring coverage of debt maturities over the next 47 months.Operating Cash Generation of US$ 204 million, about R$ 1.1 billion.The full earnings release is available on the Company's IR website: www.braskem-ri.com.br/en Braskem will host conference calls to discuss its Results Thursday, February 27 at 09:00 a.m. US ET. Additional information may be obtained from th

    $BAK
    Major Chemicals
    Industrials
  • Braskem reports Recurring EBITDA of R$2.4 billion in 3Q24, 44% higher compared to 2Q24

    Highest quarterly Recurring EBITDA since 2Q22 SÃO PAULO, Nov. 7, 2024 /PRNewswire/ --  BRASKEM S.A. ((B3: BRKM3, BRKM5 and BRKM6, NYSE:BAK, LATIBEX: XBRK)), the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 3Q24 Earnings Release. 3Q24 HIGHLIGHTS  CONSOLIDATED Recurring EBITDA of US$432 million, about 35% higher than in 2Q24 and 130% higher than in 3Q23.Cash position of US$2.4 billion, ensuring coverage of debt maturities over the next 52 months.Operating Cash Generation of US$75 million, around R$416 million, higher than 2Q24.The full earnings release is available on the Company's IR website: www.braskem-ri.com.br/en Braskem will host conf

    $BAK
    Major Chemicals
    Industrials
  • Braskem and WEAV3D® Awarded by the Society for Plastics Engineers (SPE) and American Composites Manufacturers Association (ACMA)

    WEAV3D, Clemson Composites Center & Braskem Partnership Recognized for their Innovative Rebar for Plastics® Lattice Technology Won the Most Innovative Part Award from SPE's Automotive Composites Conference & Exhibition (ACCE) Won Award for Composites Excellence (ACE), Material and Process Innovation from the ACMA Braskem ((B3: BRKM3, BRKM5, and BRKM6, NYSE:BAK, LATIBEX: XBRK)) the largest polyolefins producer in the Americas, as well as a global market leader and pioneer producer of biopolymers on an industrial scale, and WEAV3D Inc., an advanced manufacturing and materials startup, today announced Braskem's and WEAV3D Inc.'s thermoplastic composite lattice technology, in partnership wit

    $BAK
    Major Chemicals
    Industrials

$BAK
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$BAK
SEC Filings

See more

$BAK
Financials

Live finance-specific insights

See more
  • Braskem and Oxiteno sign a partnership to supply bio-attributed ethylene

    Oxiteno will receive Braskem's certified raw material for the production of new sustainable solutions, providing a breakthrough in the Brazilian chemical industry. Committed to supporting the circular economy and fighting climate change, Brazilian petrochemical companies Braskem and Indorama Ventures IOD - Oxiteno announce a partnership to supply bio-attributed ethylene from renewable sources. Bio-attributed ethylene, certified by ISCC (International Sustainability and Carbon Certification), will be used by Oxiteno to create new sustainable solutions. This raw material is the first bio-attributed chemical product produced by Braskem from the certified mass balance approach. The concep

    $BAK
    Major Chemicals
    Industrials
  • Origin Materials, Inc. Reports Operating and Financial Results for Second Quarter 2023

    – Origin 1 Initiated Start-Up, In-Line with Prior Guidance – – FDCA Mass Production Moves Forward to Origin 2, Rather Than Origin 3 as Initially Planned, Due to Strong Commercialization Progress and Higher-Margin Opportunities – – Origin 2 Outlook Updated; Phased Construction Plan Reduces Risk on Path to Profitability, with Phase 1 Start-Up Expected in Late 2026 to 2027, Phase 2 Start-Up Expected in 2028 – – Origin to Supply Para-Xylene for Bio-PET to Customers Prior to 2030 Primarily Through Collaborations with Strategic Partners – – Maintains 2023 Revenue and Adjusted EBITDA Outlook, Customer Demand Exceeds $10 Billion – Origin Materials, Inc. ("Origin," "Origin Materials," or t

    $BAK
    $ORGN
    Major Chemicals
    Industrials
  • Braskem Acquires taulman3D Expanding its Portfolio of Materials for Additive Manufacturing Applications

    The acquisition of taulman3D further accelerates Braskem's growth strategy in the additive manufacturing market with a highly complementary portfolio of 3D materials trusted by professionals worldwide. taulman3D filaments and polymers are available globally, through distributors on 6 continents Braskem ((B3: BRKM3, BRKM5, and BRKM6, NYSE:BAK, LATIBEX: XBRK)) the largest polyolefins producer in the Americas, as well as a market leader and pioneer producer of biopolymers on an industrial scale, today announced the acquisition of taulman3D, a leading 3D filament supplier of nylon, recycled PETG, and PET filaments to aerospace, automotive, healthcare, industrial, government and higher educati

    $BAK
    Major Chemicals
    Industrials